TickerFactsScreenerDevelopers

MoonLake Immunotherapeutics (MLTX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2022: $16.0K2023: $284.0K2024: $520.0K2025: $35.0K$35.0K
2022Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$35.0K-93.3%
2024$520.0K+83.1%
2023$284.0K+1674.0%
2022$16.0K—